definiens: shall mean, with respect to the first 1/3 ( one third ) of the options granted to Hadasit and tothe Scientists under the Consulting Agreement, that vest in accordance with Section 10.3.1 of theConsulting Agreement, a price per share of US$ 32.02 ( thirty two US Dollars and two cents),reflecting a 20 % ( twenty percent ) discount on the price per share paid by Teva within theframework of the investment round in the Company by Teva, HBL - Hadasit Bio - Holdings Ltd. andBioTime Inc. scheduled to be consummated in October, 2010 ( the ) and with respect tothe remaining 2/3 ( two thirds ) of the options granted to Hadasit and to the Scientists under theConsulting Agreement, that vest in accordance with Sections 10.3.2 and 10.3.3 of the ConsultingAgreement, a price per share of US$ 40.02 ( forty US Dollars and two cents ), which is the price pershare paid in the Round